The drug ACNAMINO contains one active pharmaceutical ingredient (API):
Below package inserts are available for further reading:
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
This brand name is authorized in the following countries: United Kingdom
This drug has been assigned below unique identifiers within the countries it is being marketed: